Dr. Dave Rakel introduces the ECHO model for medical decision making, a practical framework that evaluates four key factors: Efficacy (evidence of benefit), Cost, Harm (evidence of harm), and Opinion (patient preferences and bias). He emphasizes that treatment decisions should balance not only how well something works, but also its potential risks and its alignment with patient values.
He explains his evidence-versus-harm rating system, grading evidence from A to C and potential harm from 1 to 3. The ideal intervention has strong evidence with minimal harm, but he notes that therapies with moderate evidence and low risk may often be preferable to those with stronger evidence and greater potential harm.
Dr. Rakel also discusses the growing role of AI in medicine, comparing tools like Gemini, Perplexity, and Open Evidence. While AI can assist with research, he stresses that informed clinicians who use these tools thoughtfully achieve the best outcomes.
Finally, he shares clinical insights, including the use of low-dose naltrexone for fibromyalgia, the broad utility of amitriptyline, the cognitive risks associated with anticholinergic burden, and research linking processed foods, alcohol, and sugar to cognitive decline—while showing that shifting toward whole foods may significantly reduce that risk.
This guest speaker Master Class is part of the Kharrazian Institute Functional Medicine Education Program.
To become a Certified Functional Medicine practitioner, visit https://kharrazianinstitute.com/. Try our 7-day free trial, no credit card required.
00:00 "Balancing Evidence and Harm"
05:52 "Integrative Medicine: Art and Science"
08:16 "PPI Use: Risks and Bias"
10:03 "Risks of Long-Term PPI Use"
15:06 "Top Drugs for Fibromyalgia"
17:04 "Life's Essential 9 Explained"
21:22 "Optimizing Health to Prevent Dementia"
23:51 Best and Worst Brain Beverages
29:13 Functional Medicine Training Resources
Support this show http://supporter.acast.com/solving-the-puzzle-with-dr-datis-kharrazian.
Hosted on Acast. See acast.com/privacy for more information.